老年痴呆病防治研究中假说，概念和理论的研究进展

被引：10

作者：

安玉会

毛红利

机构：

[1] 郑州大学基础医学院生物化学与分子生物学教研室

来源：

河南医学研究 | 2008年 / 03期

关键词：

D O I：

暂无

中图分类号：

R749.16 [];

学科分类号：

摘要：

<正>以认知障碍和学习记忆力进行性丢失为特征的老年痴呆病(主要包括血管性痴呆和早老性痴呆)与60%的老龄人群相关。全球2000年的老年痴呆病患者为2500万人,2030年将达到6300万人,2050年预

引用

页码：262 / 265

页数：4

共 15 条

[1]

一种小分子酸性肽,其提取方法和以其为活性成分的药物组合物 [P].

安玉会 .

中国专利 :CN101121745A ,2008-02-13

[2]

早老性痴呆病研究的新进展,源头分子的调控和干预 [J].

安玉会 .

河南医学研究, 2007, (01) :84-85+96

[3]

Neuropathologic features of amnestic mild cognitive impairment..Petersen;RC;Parisi;JE;Dickson;DW;.Arch Neurol.2006,

[4]

Tacrine-induced liver damage: an analysis of 19 candidate genes [J].

Alfirevic, Ana ;

Mills, Tracy ;

Carr, Daniel ;

Barratt, Bryan J. ;

Jawaid, Ansar ;

Sherwood, James ;

Smith, John C. ;

Tugwood, Jonathan ;

Hartkoorn, Ruben ;

Owen, Andrew ;

Park, Kevin B. ;

Pirmohamed, Munir .

PHARMACOGENETICS AND GENOMICS, 2007, 17 (12) :1091-1100

[5]

Induction of Heme Oxygenase-1 In Vivo Suppresses NADPH Oxidase–Derived Oxidative Stress.[J].Srinivasa R. Datla;Gregory J. Dusting;Trevor A. Mori;Caroline J. Taylor;Kevin D. Croft;Fan Jiang.Hypertension.2007, 4

[6]

Nerve growth factor gene therapy in Alzheimer disease [J].

Tuszynski, Mark H. .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (02) :179-189

[7]

The use of a cholinesterase inhibitor review committee in long-term care [J].

Lee, Joyce ;

Monette, Johanne ;

Sourial, Nadia ;

Monette, Michele ;

Bergman, Howard .

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2007, 8 (04) :243-247

[8]

Cysteine protease inhibitors reduce brain β-amyloid and β-secretase activity in vivo and are potential Alzheimer's disease therapeutics [J].

Hook, Gregory ;

Hook, Vivian Y. H. ;

Kindy, Mark .

BIOLOGICAL CHEMISTRY, 2007, 388 (09) :979-983

[9]

Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau [J].

Li, Bin ;

Chohan, Muhammad Omar ;

Grundke-Iqbal, Inge ;

Iqbal, Khalid .

ACTA NEUROPATHOLOGICA, 2007, 113 (05) :501-511

[10]

Mild cognitive impairment: An opportunity to identify patients at high risk for progression to Alzheimer's disease [J].

Levey, Allan ;

Lah, James ;

Goldstein, Felicia ;

Steenland, Kyle ;

Bliwise, Donald .

CLINICAL THERAPEUTICS, 2006, 28 (07) :991-1001

← 1 2 →